Author, year; country | Study design and setting | Study population | Sample size (patients with AP symptoms) | MSAP cases | SAP cases | ||
Number | Proportion | Number | Proportion (%) | ||||
USA studies | |||||||
Single-centre hospital | |||||||
Bhat et al, 200718; USA | Prospective cohort; hospital | Consecutive patients with AP admitted to a single hospital within 48 hours of onset of symptoms between June 2003 and January 2005 | 91 | NR | NR | 19*a | 20.9 |
Koutroumpakis et al, 201719; Koutroumpakis et al, 201420; USA | Prospective cohort; hospital | Patients with AP enrolled at single centre from 2003 to 2014 | 400 | 94 | 23.5% | 98 | 24.5 |
Kwong et al, 201621; USA | Retrospective cohort; secondary care | Consecutive patients admitted with AP to single institution from November 2010 to December 2013 | 514 | 65 | 13% | 15*b | 3 |
Talukdar et al, 201224; USA | Prospective cohort study; three hospitals | Consecutive patients with AP presented at a single institution between June 2004 and August 2005 | 137 | 27 | 19.7% | 15*c | 10.9 |
EU-5 studies | |||||||
Single-centre hospital | |||||||
Gonzelez et al, 201125; UK | Retrospective study of prospective data; tertiary referral centre | Patients admitted with AP to tertiary referral centre between January 2008 and December 2009 | 127 | NR | NR | 32*c | 25.2 |
Multicentre hospital | |||||||
De Rai et al, 201034; Italy | Prospective cohort; 56 centres | National sample of patients with AP admitted to hospital between July 2002 and December 2011 | 1173 | NR | NR | 167*c | 14.2 |
Mole et al, 201633; UK† | Retrospective cohort; 16 health boards | National sample of patients admitted to hospital for AP between April 2009 and March 2012 | 2053 | NR | NR | 390*d | 19 |
ICU setting | |||||||
Harrison et al, 200727; UK | Retrospective cohort; general critical care units | ICNARC coding | 219 468 | NR | NR | 2677 | 1.2 |
Only studies with unselected populations for specific characteristics or comorbidities are presented.
*Severity assessment criteria: (a) APACHE II and Ranson score, (b) RAC, 2012, (c) Atlanta classification, 1992, (d) clinical presentation.
†Study providing information on the size of the subgroup with SAP populations among all those who presented with AP, included for the reporting of epidemiological outcomes.
AP, acute pancreatitis; APACHE, Acute Physiology And Chronic Health Evaluation; EU-5, European Union-5; ICNARC, Intensive Care National Audit and Research Centre; ICU, intensive care unit; MSAP, moderately severe acute pancreatitis; NR, not reported; RAC, revised Atlantic classification; SAP, severe acute pancreatitis; UK, United Kingdom; USA, United States of America.